Proposed approval of the new active constituent, oxathiapiprolin and registration of the product DuPont Zorvec Enicade Fungicide

This consultation closed on 29 January 2016.
Consultation period: 
1 December 2015 to 29 January 2016

The APVMA is considering an application to approve the new active constituent, oxathiapiprolin and considering an application for the registration of DuPont Zorvec Enicade Fungicide, containing oxathiapiprolin. The product is to be registered for the control of certain fungal disease species in oilseed poppies and vegetable crops.

We invite comment from 1 December 2015 to 29 January 2016 on whether the application for approval of the active constituent and registration of the product should be granted.

The APVMA is able to consider comments relating to the legislative grounds for approval, including:

  • occupational health and safety
  • public health
  • chemistry and manufacture
  • residues in food
  • environmental safety
  • trade
  • efficacy and target crop safety.

For more information, see APVMA Gazette Notice (page 69) from 1 December 2015APVMA Gazette Notice (page 36) from 15 December 2015 and download the Public Release Summary of the Evaluation of the New Active oxathiapiprolin in the Product DuPont Zorvec Enicade Fungicide.

Please send your written submission by email, post or fax to:

Case Management and Administration Unit 
Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
KINGSTON ACT 2604

Phone:  +61 2 6210 4701
Fax:      +61 2 6210 4721
Email:   enquiries@apvma.gov.au

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.